If hair preservation is a top priority and the primary goal is moderate weight management rather than substantial loss, these older compounds might warrant discussion with a prescriber
Supplementary Table 3 (download XLSX Oligos for shRNA and cloning
A Yale-led randomized placebo-controlled trial in 2009 tested it specifically for fibromyalgia: both the treatment group and the placebo group improved, which suggests a strong placebo or volume-expansion effect on top of any direct nutrient benefit
For continuation versus noncontinuation, the weighted prevalence ratios were 1.29 (95 percent confidence interval, 0.82 to 2.06), 1.08 (95 percent confidence interval, 0.84 to 1.40), and 1.21 (95 percent confidence interval, 0.83 to 1.82) for small for gestational age, large for gestational age, and MCM, respectively